Patients with HER2+ tumors and obesity had 28% lower odds of achieving pCR compared to those with normal weight (ORadj=0.72 [95%CI = 0.47–1.12]). Here, ERBB2 is linked to obesity due to melanocortin 4 receptor deficiency.